Rezultati pretraživanja
  1. Meet , CEO of CILcare, at the LSX World Congress in London on February 4-5! She will give a presentation about CILcare tomorrow at 4:30 PM during the Biotech Inv€€$table Showcase.

  2. prije 22 minute

    Model-based meta-analysis: an important tool for making quantitative decisions during drug development. -        

  3. prije 1 sat

    Registration is now live for the next with ABI-LAB on 2/26. Additional details can be found on the following link:

  4. prije 1 sat

    A research team from and have developed a multi Organ-on-a-Chip platform for studies. The device enables rapid quantitative predictions of human pharmacokinetic parameters. Learn more here:

  5. prije 4 sata

    Global Cancer Drug Market is expected to reach $176.509 million by 2025

  6. 31. sij

    Speaking solely as mom of a kid w/ , I’m grateful for the & thank all who joined & ran these . That said, a product that still requires allergen avoidance, 100% avail of epi, & can itself cause anaphylaxis is a 👎🏼 for me as a mom. 😞

    Prikaži ovu nit
  7. 31. sij

    From a fifth floor highrise in , MMS redefines the CRO experience via its strong, insightful team of global colleagues in HITEC CIty. Start a conversation:

  8. 31. sij

    Getting the most out of your clinical data? It’s never too late to get a biostatistics health check. Head to the new website to see how we support clinical development.

  9. 30. sij

    Writing the clinical documents of a standard NDA requires an understanding of the process, a grasp of scientific principles, and an ability to write effectively. Learn all these skills in our of NDA Clinical Modules course:

  10. 30. sij

    'This led to set up a training academy to teach and the people who care for them the basics of ; EUPATI was the first of its kind for European patients.' says Pierre Meulien - Read the full interview👉

  11. 29. sij

    Contact us at 610-296-3152 to learn more about our specializations as a contract research organization.

  12. 29. sij

    Read our latest blog, written by Rob Willacy, Materials Science team leader, to find out more about the Matwall concept, and how do crystal structures underpin commercially viable new medicines? 👉

  13. 28. sij
  14. 28. sij

    Our latest describes how precision filling significantly reduced the development time of a GMP- compliant API-in-a-capsule. Find out more about our utilisation of automatic capsule filling equipment for accelerated here:

  15. 27. sij

    You can contact us @ 610-296-3152 or info@alliancepharmaco.com to talk about your needs.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.